China
· Delayed Price · Currency is CNY Apeloa Pharmaceutical Co.,Ltd Statistics
Total Valuation
Apeloa Pharmaceutical Co.,Ltd has a market cap or net worth of CNY 19.29 billion. The enterprise value is 16.32 billion.
| Market Cap | 19.29B |
| Enterprise Value | 16.32B |
Important Dates
The next estimated earnings date is Wednesday, October 23, 2024.
| Earnings Date | Oct 23, 2024 |
| Ex-Dividend Date | May 23, 2024 |
Share Statistics
Apeloa Pharmaceutical Co.,Ltd has 1.16 billion shares outstanding. The number of shares has decreased by -0.12% in one year.
| Shares Outstanding | 1.16B |
| Shares Change (YoY) | -0.12% |
| Shares Change (QoQ) | -0.26% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 10.47% |
| Float | 534.69M |
Valuation Ratios
The trailing PE ratio is 18.02 and the forward PE ratio is 16.37.
| PE Ratio | 18.02 |
| Forward PE | 16.37 |
| PS Ratio | 1.63 |
| PB Ratio | 3.05 |
| P/FCF Ratio | 30.33 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.86, with an EV/FCF ratio of 25.67.
| EV / Earnings | 15.13 |
| EV / Sales | 1.37 |
| EV / EBITDA | 9.86 |
| EV / EBIT | 15.02 |
| EV / FCF | 25.67 |
Financial Position
The company has a current ratio of 1.30, with a Debt / Equity ratio of 0.15.
| Current Ratio | 1.30 |
| Quick Ratio | 0.98 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 0.59 |
| Debt / FCF | 1.54 |
| Interest Coverage | 22.71 |
Financial Efficiency
Return on equity (ROE) is 17.82% and return on invested capital (ROIC) is 9.67%.
| Return on Equity (ROE) | 17.82% |
| Return on Assets (ROA) | 5.19% |
| Return on Capital (ROIC) | 9.67% |
| Revenue Per Employee | 1.66M |
| Profits Per Employee | 149,711 |
| Employee Count | 7,208 |
| Asset Turnover | 0.91 |
| Inventory Turnover | 5.00 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.68% in the last 52 weeks. The beta is 0.06, so Apeloa Pharmaceutical Co.,Ltd's price volatility has been lower than the market average.
| Beta (5Y) | 0.06 |
| 52-Week Price Change | -0.68% |
| 50-Day Moving Average | 15.11 |
| 200-Day Moving Average | 14.26 |
| Relative Strength Index (RSI) | 59.03 |
| Average Volume (20 Days) | 10,627,617 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Apeloa Pharmaceutical Co.,Ltd had revenue of CNY 11.95 billion and earned 1.08 billion in profits. Earnings per share was 0.92.
| Revenue | 11.95B |
| Gross Profit | 2.82B |
| Operating Income | 1.09B |
| Pretax Income | 1.24B |
| Net Income | 1.08B |
| EBITDA | 1.64B |
| EBIT | 1.09B |
| Earnings Per Share (EPS) | 0.92 |
Balance Sheet
The company has 3.95 billion in cash and 978.42 million in debt, giving a net cash position of 2.97 billion or 2.56 per share.
| Cash & Cash Equivalents | 3.95B |
| Total Debt | 978.42M |
| Net Cash | 2.97B |
| Net Cash Per Share | 2.56 |
| Equity (Book Value) | 6.34B |
| Book Value Per Share | 5.46 |
| Working Capital | 2.09B |
Cash Flow
In the last 12 months, operating cash flow was 1.27 billion and capital expenditures -633.82 million, giving a free cash flow of 635.95 million.
| Operating Cash Flow | 1.27B |
| Capital Expenditures | -633.82M |
| Free Cash Flow | 635.95M |
| FCF Per Share | 0.55 |
Margins
Gross margin is 23.63%, with operating and profit margins of 9.10% and 9.03%.
| Gross Margin | 23.63% |
| Operating Margin | 9.10% |
| Pretax Margin | 10.34% |
| Profit Margin | 9.03% |
| EBITDA Margin | 13.75% |
| EBIT Margin | 9.10% |
| FCF Margin | 5.32% |
Dividends & Yields
This stock pays an annual dividend of 0.32, which amounts to a dividend yield of 1.78%.
| Dividend Per Share | 0.32 |
| Dividend Yield | 1.78% |
| Dividend Growth (YoY) | 6.70% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 38.22% |
| Buyback Yield | 0.12% |
| Shareholder Yield | 1.90% |
| Earnings Yield | 5.55% |
| FCF Yield | 3.30% |
Stock Splits
The last stock split was on May 30, 2014. It was a forward split with a ratio of 1.3.
| Last Split Date | May 30, 2014 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
Apeloa Pharmaceutical Co.,Ltd has an Altman Z-Score of 3.37.
| Altman Z-Score | 3.37 |
| Piotroski F-Score | n/a |